Financial Year |
March 31 2023 |
Monetary Funds |
953,006,393.21 |
Held-for-trading Financial Assets |
18,156,205.48 |
Notes Receivable |
-- |
Accounts Receivable |
2,480,290,407.21 |
Advances to Suppliers |
73,991,164.85 |
Other Receivables |
11,745,847.78 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
797,143,098.54 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
784,482,671.60 |
Total Current Assets |
5,118,815,788.67 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
49,206.78 |
Fixed Assetes |
1,691,056,307.55 |
Under-construction Projects |
3,602,178,122.09 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
353,126,067.44 |
R&D expenses |
132,580,598.04 |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
72,181,967.70 |
Deferred Income Tax Assets |
672,220,268.11 |
Other Non-Current Assets |
2,162,433,327.89 |
Sub-Total of Non-Current Assets |
8,685,825,865.60 |
Total Assets |
13,804,641,654.27 |
Short-Term Loans |
167,308,333.33 |
Trading Financial liabilities |
-- |
Notes Payable |
153,776,528.00 |
Accounts Payable |
291,917,318.38 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
28,868,295.48 |
Taxes Payable |
23,355,923.03 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
1,401,880,488.92 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
105,594,863.70 |
Other Current Liabilities |
895,406.27 |
Sub-Total of Current Liabilities |
2,203,444,033.28 |
Long-term Loans |
442,820,248.84 |
Bonds Payable |
1,633,959,986.97 |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
23,853,727.77 |
Deferred Income Tax Liabilities |
26,046,134.36 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
2,511,345,302.22 |
Total Liabilities |
4,714,789,335.50 |
Paid-In Capital(Or Share Stock) |
1,116,912,345.00 |
Capital Surplus |
5,372,351,370.70 |
Surplus Reserve |
242,899,806.53 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
1,846,550,476.78 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,089,852,318.77 |
Owner's Equity(Stockholder's Equity) |
9,089,852,318.77 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
13,804,641,654.27 |